Supernus Pharmaceuticals Return on Equity:-178.2% for Dec. 31, 2012
Supernus Pharmaceuticals Return on Equity Chart
Supernus Pharmaceuticals Historical Return on Equity DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||-178.2%|
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
SUPN Return on Equity Benchmarks
|Catalyst Pharmaceutical Partners||-55.23%|
SUPN Return on Equity Rankings
4508 of 8009
474 of 687 in Healthcare
49 of 69 in Drug Manufacturers - Specialty & Generic
SUPN Return on Equity Range, Past 5 Years
GlobeNewswire May 20
Street Insider May 17